Stock listing

OTC:CASBF CanSino Biologics, Inc. Stock

US listing (OTC) of CanSino Biologics, Inc. · home listing Shanghai:688185

Follow CanSino Biologics, Inc. into a list and get an email when it puts out news.

Share price · OTC:CASBF

$3.35 USD 0.00 (0.0%)

Close on Oct 21, 2026

Day range
$3.35 – $3.35 USDOct 21, 2026
Market cap
$827.6M USDAt the close on Oct 21, 2026 · price × 247.0M shares outstanding
CanSino Biologics, Inc. logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Shanghai:688185 · Home¥79.67 CNY+0.52 (+0.7%)8,212,690¥81.02¥83.11¥79.13¥79.15Close on Oct 21, 2026
HKEX:6185$30.10 HKD+0.80 (+2.7%)3,976,153$30.20$31.20$29.86$29.30Close on Oct 21, 2026
Frankfurt:CJH€3.36 EUR+0.08 (+2.4%)—€3.36€3.36€3.36€3.28Close on Oct 21, 2026
OTC:CASBF$3.35 USD0.00 (0.0%)—$3.35$3.35$3.35$3.35Close on Oct 21, 2026
Ticker
OTC:CASBF
Asset type
Stock
Exchange
OTC
Currency
USD

What changed lately

Latest news

Announcement on Receipt of Government Subsidies

Oct 13, 2026

Announcement on Granting Certain Reserved Restricted Shares to Participants under the 2025 A-Share Restricted Share Incentive Plan

Sep 17, 2026

Announcement on Participating in the 2026 Semi-annual Collective Performance Briefing for the STAR Market Biological Products and CXO Industry

Sep 5, 2026

Semi-annual Report for 2026

Aug 28, 2026

Announcement on Attending the 2026 Online Collective Reception Day for Investors of Listed Companies in Tianjin Jurisdiction and Semi-annual Performance Briefing

Aug 26, 2026

Announcement on Abnormal Fluctuations in Stock Trading

Aug 22, 2026

Announcement on Obtaining Drug Registration Certificate for Adsorbed Tetanus Vaccine

Aug 21, 2026

Announcement on Voluntary Disclosure of Acceptance of the Drug Registration Application for Adsorbed Tetanus, Diphtheria and Pertussis (Acellular, Five Components) Combined Vaccine (For Persons Aged 6 and Above)

Aug 17, 2026

CanSino Biologics: CanSinoBIO's Menhycia® Application Accepted by China's NMPA for Expanded Use in Population Aged 3 Months to 17 Years

Jul 19, 2026

CanSino Biologics: CanSinoBIO's MCV4 Receives Registration Approval in Argentina, Expanding Global Reach

Jun 25, 2026

All CanSino Biologics, Inc. news

CanSino Biologics, Inc. on 6ix

News releases
31 in the last 12 months · 60 in all · newest Oct 13, 2026 · oldest 2024

Where CanSino Biologics, Inc. is listed

ListingExchangeCountryCurrency
Shanghai:688185 康希诺 · Home listingShanghaiChinaCNY
HKEX:6185 康希諾生物HKEXHong KongHKD
gettex:CJHgettexGermanyEUR
Dusseldorf:CJHDusseldorfGermanyEUR
Frankfurt:CJHFrankfurtGermanyEUR
LS Exchange:A2PGFWLS ExchangeGermanyEUR
OTC:CASBF · This pageOTCUnited StatesUSD
Stuttgart:CJHStuttgartGermanyEUR
Lang & Schwarz:A2PGFWLang & SchwarzGermanyEUR
Tradegate:CJHTradegateGermanyEUR
Munich:CJHMunichGermanyEUR
Hamburg:CJHHamburgGermanyEUR

Log in to ask 6ix AI your own questions about CanSino Biologics, Inc.